v3.22.2.2

Subsequent Events | 12 Months Ended
--- | ---
Dec. 31, 2019
Subsequent Events [Abstract] |
Subsequent Events | Note H – Subsequent Events The Company has analyzed events occurring subsequent to December 31, 2019, through the date these financial statements were issued, and noted the following material items requiring disclosure herein: (1) On January 15, 2020, Robert W. Ferguson, our CEO, and Fred J. Popke, our COO, were each issued 450,000 shares of Series A convertible preferred stock in exchange for $25 each. (2) The Company’s Nevada office was closed on April 30, 2020, and the other leases have since been converted to month-to-month obligations of under $300/month. (3) On January 17, 2020, John J. Carvelli and James Mason resigned as officers and directors of the Company, and on February 19, Carl L. Engstrom was appointed an independent director. The resignations of Mr. Carvelli and Mr. Mason were not the result of any disagreement on any matter relating to the Company’s operations, policies or practices. (4) On February 1, 2021, the Company issued to an independent investor a convertible promissory note with a face value of $35,000, maturity date of February 1, 2022, and stated interest of 8%. The note is convertible at any time after the funding of the note into the Company’s common stock at a fixed conversion rate of $ .0001 per share. The note was funded on February 4, 2021, when the Company received proceeds of $22,279, after disbursements for the lender’s transaction costs, fees and expenses which in aggregate resulted in a total discount of $3,000 to be amortized to interest expense over the life of the note and payment of certain outstanding fees to our transfer agent in the amount of $10,278. (5) On February 10, 2021, the Company issued to an independent investor a convertible promissory note with a face value of $84,750, maturity date of February 10, 2022, and stated interest of 10%. The note is convertible at any time after 6 months of the funding of the note into a variable number of the Company’s common stock, based on a conversion rate of 60%. The note was funded on February 12, 2021, when the Company received proceeds of $75,750, after disbursements for the lender’s transaction costs, fees and expenses which in aggregate resulted in a total discount of $9,000 to be amortized to interest expense over the life of the note. (6) On March 11, 2020, the Board of Directors amended the Company’s Articles of Incorporation to increase the number of authorized common shares from 15,000,000,000 to 300,000,000,000, as retroactively reflected in the financial statements. (7) During the period January 1, 2020, through July 27, 2022 holders of our convertible notes payable elected to convert $1,679,860 in principle in exchange for 13,288,670,557 shares of common stock, and $494,058 in accrued interest in exchange for 3,134,023,238 shares of common stock. We also issued 333,840,157 shares of our common stock for $28,300 in conversion fees. These issuances ranged in price from $.00003 to $.0011 per share. Total common shares issued for principal, accrued interest and conversion fees was 16,713,533,953 valued at $2,199,638 (8) In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic, which continues to spread throughout the world. While the disruption is currently expected to be temporary, there is uncertainty around its duration. As a result of COVID-19 mobility restrictions globally, there have been changes in consumer behavior. We expect these changes in behavior to continue to evolve as the pandemic progresses. The impacts seen to date may continue to create a wider range of outcomes as consumer behaviors and mobility restrictions continue to evolve. The Covid 19 pandemic has impacted our business resulting in the cancellation of certain business contracts and eliminated our ability to raise additional capital. Management will continue to explore business opportunities with patented technology that it feels it has the expertise and resources to commercialize utilizing the Company’s capital structure.

X
- References No definition available. + Details
Name: | us-gaap_SubsequentEventsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 855 -URI https://asc.fasb.org/topic&trid=2122774 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 855 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662 + Details
Name: | us-gaap_SubsequentEventsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration